| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 01/13/2005 | US20050009855 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives; these compounds interfere with the E1-E2-DNA complex during initiation of DNA replication |
| 01/13/2005 | US20050009812 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 01/13/2005 | US20050009788 The analog includes a conjugated polyene with 7 to 14 double bonds and a 3,3-dimethylcyclohexenylene or 3,3-dimethylcyclohexen-6-onylene ring; especially for treating cardiac arrhythmia and cancerous and pre-cancerous cells |
| 01/13/2005 | US20050009758 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 01/13/2005 | US20050009706 Herbicides; plant safening agents |
| 01/13/2005 | US20050009109 Fluorophore compounds and their use in biological systems |
| 01/13/2005 | US20050009076 Conjugate of hormone (thyroxine) and inosine-5'-monophosphate dehydrogenase inhibitor (such as mycophenolic acid) |
| 01/13/2005 | DE10297418T5 Maleinsäure-Derivat und härtbare Zusammensetzung, die dieses enthält Maleic acid derivative and curable composition containing this |
| 01/13/2005 | CA2530884A1 Trp-p8 active compounds and therapeutic treatment methods |
| 01/12/2005 | EP1496054A1 Medicinal composition for improving angiotension-regulating function of blood vessel endothelium |
| 01/12/2005 | EP1495806A1 Practical chiral zirconium catalyst |
| 01/12/2005 | EP1495015A1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers |
| 01/12/2005 | EP1495013A1 Process and intermediates for preparing escitalopram |
| 01/12/2005 | EP1495012A2 Recovery and purification of anhydro sugar alcohols from a vapor stream |
| 01/12/2005 | EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1494995A1 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1494663A1 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss |
| 01/12/2005 | EP1414435B1 Crystalline composition containing escitalopram |
| 01/12/2005 | EP1105370B9 Novel aryl sulphonamides and analogues |
| 01/12/2005 | CN1564684A Pharmaceutical compositions |
| 01/12/2005 | CN1562990A Method for preparing 1-methyl-4-isopropyl-bicyclo [2, 2, 2] octane-2, 3 diacid anhydride |
| 01/12/2005 | CN1562989A Method for purifying compound of anhydrides aromatic carboxylic acid |
| 01/12/2005 | CN1562477A Catalyzer for preparing furfuryl alcohol through hydrogenation in liquid phase furfural |
| 01/12/2005 | CN1562474A Coupled method of preparing catalyst of gamma-butyolactone and usage |
| 01/12/2005 | CN1562473A Preparing catalyzer of Gamma-butyrolactone through dehydrogenating 1, 4 butanediol |
| 01/12/2005 | CN1184220C Process for preparation of 5-carboxy-phthalide and its use for production of CITALOPRAM |
| 01/11/2005 | US6841688 Dehydrating 2-tetrahydrofuran amide in the presence of a dehydrating agent and an amine base to obtain 2-tetrahydrofuran nitrile that is reacted with a nuleophile followed by hydrolysis with an aqueous acidic solution |
| 01/11/2005 | US6841667 Nucleophilic kinetic resolution of cyclic substrates using silyl azides |
| 01/11/2005 | US6841571 Compounds useful as reversible inhibitors of cysteine proteases |
| 01/11/2005 | US6841569 Treatment of central nervous system disorders; anticonvulsants, antiepileptics, neuroprotective agents and muscle relaxants |
| 01/11/2005 | US6840965 P-aminophenols and colorants containing said compounds |
| 01/06/2005 | WO2005000839A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | WO2005000829A1 Cannabinoid receptor modulator |
| 01/06/2005 | WO2005000791A1 2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
| 01/06/2005 | WO2005000781A1 Biaryloxymethylarene-carboxylic acids |
| 01/06/2005 | US20050004380 Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido]-3-substituted-3-cephem-4-carboxylic acid |
| 01/06/2005 | US20050004369 Phenyl substituted carboxylic acids |
| 01/06/2005 | US20050004235 Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease |
| 01/06/2005 | US20050004167 Such as dibenzofuran-2-carboxylic acid 2-(phenylsulfonyl)hydrazide |
| 01/06/2005 | US20050004136 Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful as neurokinin receptor modulators |
| 01/06/2005 | US20050004116 Triazole inhibitors of type 2 methionine aminopeptidase |
| 01/06/2005 | US20050004112 C-fms kinase inhibitors |
| 01/06/2005 | US20050004086 Indene derivatives as pharmaceutical agents |
| 01/06/2005 | CA2672071A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | CA2531020A1 Cannabinoid receptor modulator |
| 01/06/2005 | CA2530377A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | CA2529875A1 Biaryloxymethylarene-carboxylic acids |
| 01/05/2005 | EP1493441A1 Therapeutic agent for food competence disorder in stomach |
| 01/05/2005 | EP1492773A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 01/05/2005 | EP1492595A1 Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist |
| 01/05/2005 | CN1561333A Aromatic and heteroaromatic acid halides for synthesizing polyamides |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1561326A Alpha-haloenamine reagents |
| 01/05/2005 | CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
| 01/05/2005 | CN1560045A Process of producing monocholo benzen anhydride by continuous liquid phase oxydation |
| 01/05/2005 | CN1560044A Compound of 3, 15-dicarbonyl erythro mildew acid kind and its ester and salt |
| 01/05/2005 | CN1560043A Process for counter-current extracting separating fural in water solution |
| 01/05/2005 | CN1560041A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 01/05/2005 | CN1183126C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 01/05/2005 | CN1183125C Preparation method of ascorbic acid aliphatic ester |
| 01/05/2005 | CN1183098C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
| 01/05/2005 | CN1183081C Preparation of 1,4-butanediol |
| 01/05/2005 | CN1182903C Sonic impact jet crystallization apparatus and process |
| 01/05/2005 | CN1182870C Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
| 01/04/2005 | US6838474 Prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. This invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solubility, high oral bioavailability and |
| 01/04/2005 | US6838471 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| 01/04/2005 | US6838128 Comprises chiral, nonracemic gamma-lactone tail |
| 01/04/2005 | CA2186015C Nicotinic acid derivatives and herbicides |
| 12/30/2004 | US20040267030 Novel process for the preparation of form 1 ranitidine hydrochloride |
| 12/30/2004 | US20040267029 Such as hydroxymatairesinol via solvent extraction, concentrating, complexing with potassium acetate, precipitating, then releasing from complex; crystallization |
| 12/30/2004 | US20040266864 Possess potent serotonin reuptake inhibitory activity, with minimal inhibitory effects on the reuptake of other known monoamines, e.g., norepinephrine or dopamine; also useful for treating or preventing other CNS disorders, cerebrovascular or vascular dysfunctions, sexual dysfunctiions, eating disorders |
| 12/30/2004 | US20040266856 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 12/30/2004 | US20040266789 Substituted amino carboxylic acids |
| 12/30/2004 | US20040266788 treatment of diabetes and/or cancer; useful in the treatment of syndrome X; capable of inhibiting Protein tyrosine phosphatase |
| 12/30/2004 | US20040266782 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 12/30/2004 | US20040266764 Hydroxamic acid derivatives |
| 12/30/2004 | US20040266723 Antiviral agents for treatment of Flaviviridae infections |
| 12/30/2004 | US20040265732 Unsaturated monomers, polymers, chemically amplified resist composition, and process of pattern formation |
| 12/30/2004 | US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 12/30/2004 | US20040262161 Partial evaporative crystallization; and displacement precipitation of the salt |
| 12/29/2004 | WO2004113331A1 Novel compounds that modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 12/29/2004 | WO2004113316A1 Benzofuran inhibitors of factor viia |
| 12/29/2004 | WO2004113315A2 Production of 5-methyl-dihydro-furan-2-one from levulinic acid in supercritical media |
| 12/29/2004 | WO2004113281A1 Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
| 12/29/2004 | WO2004113278A2 Acylsulfamide inhibitors of factor viia |
| 12/29/2004 | WO2004113273A1 Pesticidally active ketone and oxime derivatives |
| 12/29/2004 | WO2004099175A3 Blockers of the quorum sensing system of gram-negative bacteria |
| 12/29/2004 | WO2004075853A3 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 12/29/2004 | WO2004063129A3 Methods for nucleophilic fluoromethylation |
| 12/29/2004 | WO2004002940A8 Inhibitors of hcv ns5b polymerase |
| 12/29/2004 | EP1491541A1 Pyridazinone aldose reductase inhibitors |
| 12/29/2004 | EP1491540A1 Pyridazinone aldose reductase inhibitors |
| 12/29/2004 | EP1491538A1 Anti-mitotic agents which inhibit tubulin polymerization |
| 12/29/2004 | EP1490349A1 Therapeutic ion channel blocking agents and methods of use thereof |
| 12/29/2004 | EP1490339A1 Novel chalcone derivatives and uses thereof |
| 12/29/2004 | EP1490318A1 Liquid phase oxidation of halogenated ortho-xylenes |
| 12/29/2004 | EP1490317A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/29/2004 | EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |